320 related articles for article (PubMed ID: 33804775)
1. High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients.
Giansanti M; Karimi T; Faraoni I; Graziani G
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804775
[TBL] [Abstract][Full Text] [Related]
2. Ascorbic acid, but not dehydroascorbic acid increases intracellular vitamin C content to decrease Hypoxia Inducible Factor -1 alpha activity and reduce malignant potential in human melanoma.
Fischer AP; Miles SL
Biomed Pharmacother; 2017 Feb; 86():502-513. PubMed ID: 28012930
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice.
Campbell EJ; Vissers MCM; Wohlrab C; Hicks KO; Strother RM; Bozonet SM; Robinson BA; Dachs GU
Free Radic Biol Med; 2016 Oct; 99():451-462. PubMed ID: 27567539
[TBL] [Abstract][Full Text] [Related]
4. Review of high-dose intravenous vitamin C as an anticancer agent.
Wilson MK; Baguley BC; Wall C; Jameson MB; Findlay MP
Asia Pac J Clin Oncol; 2014 Mar; 10(1):22-37. PubMed ID: 24571058
[TBL] [Abstract][Full Text] [Related]
5. Expression and/or activity of the SVCT2 ascorbate transporter may be decreased in many aggressive cancers, suggesting potential utility for sodium bicarbonate and dehydroascorbic acid in cancer therapy.
McCarty MF
Med Hypotheses; 2013 Oct; 81(4):664-70. PubMed ID: 23916956
[TBL] [Abstract][Full Text] [Related]
6. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells.
Wohlrab C; Kuiper C; Vissers MC; Phillips E; Robinson BA; Dachs GU
Hypoxia (Auckl); 2019; 7():17-31. PubMed ID: 31192266
[No Abstract] [Full Text] [Related]
7. Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.
Jóźwiak P; Ciesielski P; Zaczek A; Lipińska A; Pomorski L; Wieczorek M; Bryś M; Forma E; Krześlak A
J Biomed Sci; 2017 Oct; 24(1):83. PubMed ID: 29084538
[TBL] [Abstract][Full Text] [Related]
8. Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence.
Vissers MCM; Das AB
Front Physiol; 2018; 9():809. PubMed ID: 30018566
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. SVCT-2 in breast cancer acts as an indicator for L-ascorbate treatment.
Hong SW; Lee SH; Moon JH; Hwang JJ; Kim DE; Ko E; Kim HS; Cho IJ; Kang JS; Kim DJ; Kim JE; Shin JS; Jung DJ; Jeong YJ; Cho BJ; Kim TW; Lee JS; Kang JS; Hwang YI; Noh DY; Jin DH; Lee WJ
Oncogene; 2013 Mar; 32(12):1508-17. PubMed ID: 22665050
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic ascorbate (P-AscH
Wilkes JG; O'Leary BR; Du J; Klinger AR; Sibenaller ZA; Doskey CM; Gibson-Corley KN; Alexander MS; Tsai S; Buettner GR; Cullen JJ
Clin Exp Metastasis; 2018 Feb; 35(1-2):37-51. PubMed ID: 29396728
[TBL] [Abstract][Full Text] [Related]
12. PARP-1 modulates deferoxamine-induced HIF-1alpha accumulation through the regulation of nitric oxide and oxidative stress.
Martínez-Romero R; Martínez-Lara E; Aguilar-Quesada R; Peralta A; Oliver FJ; Siles E
J Cell Biochem; 2008 Aug; 104(6):2248-60. PubMed ID: 18459142
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C as a Modulator of the Response to Cancer Therapy.
Blaszczak W; Barczak W; Masternak J; Kopczyński P; Zhitkovich A; Rubiś B
Molecules; 2019 Jan; 24(3):. PubMed ID: 30695991
[TBL] [Abstract][Full Text] [Related]
14. Vitamin C protects against UV irradiation-induced apoptosis through reactivating silenced tumor suppressor genes p21 and p16 in a Tet-dependent DNA demethylation manner in human skin cancer cells.
Lin JR; Qin HH; Wu WY; He SJ; Xu JH
Cancer Biother Radiopharm; 2014 Aug; 29(6):257-64. PubMed ID: 25003799
[TBL] [Abstract][Full Text] [Related]
15. SVCT-2 determines the sensitivity to ascorbate-induced cell death in cholangiocarcinoma cell lines and patient derived xenografts.
Wang C; Lv H; Yang W; Li T; Fang T; Lv G; Han Q; Dong L; Jiang T; Jiang B; Yang G; Wang H
Cancer Lett; 2017 Jul; 398():1-11. PubMed ID: 28385602
[TBL] [Abstract][Full Text] [Related]
16. The role of vitamin C in epigenetic regulation.
Guz J; Oliński R
Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):747-760. PubMed ID: 28894047
[TBL] [Abstract][Full Text] [Related]
17. Vitamin C pharmacokinetics: implications for oral and intravenous use.
Padayatty SJ; Sun H; Wang Y; Riordan HD; Hewitt SM; Katz A; Wesley RA; Levine M
Ann Intern Med; 2004 Apr; 140(7):533-7. PubMed ID: 15068981
[TBL] [Abstract][Full Text] [Related]
18. In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease.
Starczak M; Zarakowska E; Modrzejewska M; Dziaman T; Szpila A; Linowiecka K; Guz J; Szpotan J; Gawronski M; Labejszo A; Liebert A; Banaszkiewicz Z; Klopocka M; Foksinski M; Gackowski D; Olinski R
J Transl Med; 2018 Jul; 16(1):204. PubMed ID: 30029654
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism(s) involved in differential expression of vitamin C transporters along the intestinal tract.
Subramanian VS; Srinivasan P; Wildman AJ; Marchant JS; Said HM
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G340-G347. PubMed ID: 27932501
[TBL] [Abstract][Full Text] [Related]
20. The Association Between Ascorbate and the Hypoxia-Inducible Factors in Human Renal Cell Carcinoma Requires a Functional Von Hippel-Lindau Protein.
Wohlrab C; Vissers MCM; Phillips E; Morrin H; Robinson BA; Dachs GU
Front Oncol; 2018; 8():574. PubMed ID: 30555801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
